115 related articles for article (PubMed ID: 7576743)
1. p53 expression and the result of adjuvant therapy of breast cancer.
Stål O; Stenmark Askmalm M; Wingren S; Rutqvist LE; Skoog L; Ferraud L; Sullivan S; Carstensen J; Nordenskjöld B
Acta Oncol; 1995; 34(6):767-70. PubMed ID: 7576743
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.
Stål O; Sullivan S; Wingren S; Skoog L; Rutqvist LE; Carstensen JM; Nordenskjöld B
Eur J Cancer; 1995 Dec; 31A(13-14):2185-90. PubMed ID: 8652240
[TBL] [Abstract][Full Text] [Related]
4. Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.
Askmalm MS; Carstensen J; Nordenskjöld B; Olsson B; Rutqvist LE; Skoog L; Stål O
Acta Oncol; 2004; 43(3):235-44. PubMed ID: 15244246
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
[TBL] [Abstract][Full Text] [Related]
6. The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer.
Söderlund Leifler K; Asklid A; Fornander T; Stenmark Askmalm M
J Cancer Res Clin Oncol; 2015 May; 141(5):797-804. PubMed ID: 25354554
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
8. p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancer.
Dublin EA; Miles DW; Rubens RD; Smith P; Barnes DM
Int J Cancer; 1997 Dec; 74(6):605-8. PubMed ID: 9421356
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
Specht K; Harbeck N; Smida J; Annecke K; Reich U; Naehrig J; Langer R; Mages J; Busch R; Kruse E; Klein-Hitpass L; Schmitt M; Kiechle M; Hoefler H
Breast Cancer Res Treat; 2009 Nov; 118(1):45-56. PubMed ID: 18925433
[TBL] [Abstract][Full Text] [Related]
10. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.
Waltersson MA; Askmalm MS; Nordenskjöld B; Fornander T; Skoog L; Stål O
Int J Oncol; 2009 Feb; 34(2):441-8. PubMed ID: 19148479
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
13. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD
J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.
Niméus-Malmström E; Ritz C; Edén P; Johnsson A; Ohlsson M; Strand C; Ostberg G; Fernö M; Peterson C
Eur J Cancer; 2006 Nov; 42(16):2729-37. PubMed ID: 17023159
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
Joaquim AI; Sagarra AJ; Ramos CD; Coudry R; Sagarra RA; Camargo EE
Clin Nucl Med; 1997 Sep; 22(9):638-40. PubMed ID: 9298303
[No Abstract] [Full Text] [Related]
19. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.
Ejlertsen B; Mouridsen HT; Jensen MB; Andersen J; Andersson M; Kamby C; Knoop AS;
Cancer; 2010 May; 116(9):2081-9. PubMed ID: 20186830
[TBL] [Abstract][Full Text] [Related]
20. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
